GIV Mobile and its customers support the fight against Alzheimer’s

GIV Mobile and its customers support the fight against Alzheimer’s

GIV Mobile, a no-contract wireless company, will donate 8 percent of customers’ monthly bills to the Alzheimer’s Association when they select the Association as their charity of choice, now through July 15, 2014. GIV Mobile will also donate an additional $10 per phone activated through March 31, 2014, using one of the promotion codes found in the October and January issues of SkyMall magazine.

GIV Mobile, a provider of affordable no-contract mobile service, is helping to advance Alzheimer’s research, care and support by donating up to 8 percent of users’ monthly cell phone payments* to benefit the Alzheimer’s Association. GIV Mobile is further supporting the mission of the Association by donating an additional $10 per activation through March 31st, for new customers using promotion codes from GIV Mobile ads in the October and January issues of SkyMall Magazine.

Dedicated to paying good forward by turning affordable wireless service into a vehicle for giving, GIV Mobile invites customers to select up to three charities to receive 8 percent of their monthly payment. This allows its community of members who want to make a difference to have an impact on the charities they care about.

GIV Mobile is a brand of PTel Mobile, one of the original no-contract wireless providers in the United States. PTel Mobile has been providing affordable wireless service since 2001. To learn more visit

* GIV Mobile will donate up to 8 percent of monthly cell phone payments through July 15, 2014, for customers who select the Alzheimer’s Association as one of their charities of choice, with a minimum guaranteed donation of $25,000. In addition, GIV Mobile will donate $10 for every new account activated from October 1, through March 31, 2014, using one of the activation codes from SkyMall magazine.

Alzheimer’s Association bow tie to be featured during World Series

Alzheimer’s Association bow tie to be featured during World Series

FOX Sports baseball reporter Ken Rosenthal will be wearing an Alzheimer’s Association bow tie during Game 6 of the 2013 World Series on Wednesday night, Oct. 30, to help raise Alzheimer’s awareness. Rosenthal also wore an Association bow tie during last year’s World Series.

Number of gene variants linked to Alzheimer’s disease doubles

Number of gene variants linked to Alzheimer’s disease doubles

Scientists have discovered 11 new genes that may be tied to the late-onset form of Alzheimer’s disease, a new study shows. Eleven gene variants had previously been linked to late-onset Alzheimer’s, including the APOE-e4 gene that appeared to have the strongest impact on risk. This latest research doubles the known Alzheimer’s disease gene variants. The Alzheimer’s Association co-funded the formation of the International Genomics of Alzheimer’s Disease Project (IGAP) that conducted this study.

New Gene Variants Linked to Alzheimer’s Discovered

11 New Gene Variants Linked to Late-Onset Alzheimer’s Discovered

The International Genomics of Alzheimer’s Project (IGAP), the largest international Alzheimer’s disease genetics collaboration to date, has found 11 new genetic “areas of interest” that may contribute to late-onset Alzheimer’s disease. This doubles the number of potential genetics-based therapeutic targets to investigate in Alzheimer’s. The study was published online by Nature Genetics on Sunday, October 27.

In 2011, IGAP was formed to discover and map the genes that contribute to Alzheimer’s disease. The formation of this landmark international collaboration was funded by the Alzheimer’s Association and the Fondation Plan Alzheimer. The collaborative effort, spanning universities and research centers from both Europe and the United States, combines the knowledge, staff and resources of four consortia that conduct research on Alzheimer’s disease genetics.

The new genetic findings expand the scope of our understanding of Alzheimer’s to new areas, including the immune system, where a genetic overlap was identified with other neurodegenerative diseases such as multiple sclerosis and Parkinson’s disease.

This is extremely important research in taking our ability to detect and treat Alzheimer’s disease to the next level. Identification of genes that contribute to Alzheimer’s risk and influence the progression of disease may:

  • Help lead us to the cause of the disease.
  • Identify proteins and other new targets for drug development.
  • Provide genetic methods for determining which people are at greatest risk for Alzheimer’s when preventative measures become available.

Learn More

Alzheimer’s Association Involvement

The Alzheimer’s Association is pleased to fund this project that brings together four well-established and highly regarded research groups to enable an unprecedented sharing and analysis of Alzheimer’s disease genetic data. These results would not be possible without large-scale collaborative efforts, such as IGAP, which bring larger study populations and increased resources to solving the problem of Alzheimer’s disease. Only by working together can they amass a large enough group of participants to accelerate gene discovery. For example, in the newly published study, pooling resources through IGAP, the collaborative team was able to collect 74,076 participants (including people with Alzheimer’s and controls) from 15 countries.

Map out a plan to approach Alzheimer’s diseases – Alzheimer’s Association

Map out a plan to approach Alzheimer’s diseases

The Alzheimer’s Association is here to support those facing Alzheimer’s disease. Through each stage of the disease, as families face decisions, plan for future care and build a team for support, we’re here to help.
With a vast amount of information available, it can be difficult to know where to begin. Personalized help starts with Alzheimer’s Association Alzheimer’s Navigator®, an easy-to-use online tool that guides people through the disease. If you or someone you know needs our help, we’ve made it easy.
Here’s how it works: